Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
Psoriasis is an immune-mediated skin condition. There are many therapeutic options for its treatment; however, none of them is completely effective. Tapinarof is a promising new active substance; it was recently approved by the FDA for the treatment of psoriasis. The aim of our study was to prepare...
Saved in:
| Main Authors: | Barbara Balogh, Ágota Pető, Ádám Haimhoffer, Dávid Sinka, Dóra Kósa, Pálma Fehér, Zoltán Ujhelyi, Monica Argenziano, Roberta Cavalli, Ildikó Bácskay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Gels |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2310-2861/10/11/675 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tapinarof Nanogels as a Promising Therapeutic Approach
by: Barbara Balogh, et al.
Published: (2025-06-01) -
Characteristics and management of follicular events and contact dermatitis in patients using tapinarof cream for the treatment of atopic dermatitis or plaque psoriasis
by: Linda Stein Gold, et al.
Published: (2025-12-01) -
Development of <i>Salvia officinalis</i>–Based Self-Emulsifying Systems for Dermal Application: Antioxidant, Anti-Inflammatory, and Skin Penetration Enhancement
by: Krisztina Bodnár, et al.
Published: (2025-01-01) -
Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review
by: Ildikó Bácskay, et al.
Published: (2025-01-01) -
Flavonoid-Based Nanogels: A Comprehensive Overview
by: Sergio Liga, et al.
Published: (2025-04-01)